Sign In
Buy BBI
$1.94
+0 (+0%)
At Close: Feb 07, 2023
4 Reddit Penny Stocks To Buy On Robinhood For Under $1 Right Now
04:18pm, Sunday, 25'th Apr 2021
Penny stocks on Robinhood are a big focus for Reddit traders in April The post 4 Reddit Penny Stocks To Buy On Robinhood For Under $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and I
Biotech Penny Stocks To Buy? 3 to Watch Under $5
05:27pm, Friday, 23'rd Apr 2021
Biotech stocks are more popular than ever; here are 3 to watch under $5 The post Biotech Penny Stocks To Buy? 3 to Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | P
Daily treatment with sofpironium bromide gel was generally well-tolerated over 48 weeks of treatment
BOULDER, Colo., April 16, 2021 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative
BBI Stock Price Increases Over 8% Pre-Market: Why It Happened
07:17am, Thursday, 18'th Mar 2021
The stock price of Brickell Biotech Inc (NASDAQ: BBI) has increased by over 8% pre-market. This is why it happened.
Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q4 2020 Results - Earnings Call Transcript
10:43pm, Tuesday, 09'th Mar 2021
Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q4 2020 Results - Earnings Call Transcript
Brickell (BBI) Reports Q4 Loss, Misses Revenue Estimates
06:57pm, Tuesday, 09'th Mar 2021
Brickell (BBI) delivered earnings and revenue surprises of -87.50% and -97.30%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Brickell Biotech Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
04:01pm, Tuesday, 09'th Mar 2021
Initiated U.S. pivotal Phase 3 clinical program (Cardigan I and II studies) evaluating sofpironium bromide gel, 15% for the treatment of primary axillary (underarm) hyperhidrosis
Brickell Biotech To Host Key Opinion Leader Webinar on the Hyperhidrosis Market
08:00am, Friday, 05'th Mar 2021
Webinar taking place on Friday, March 26th @ 10 am EDT Webinar taking place on Friday, March 26th @ 10 am EDT
Will Brickell (BBI) Report Negative Earnings Next Week? What You Should Know
01:38pm, Tuesday, 02'nd Mar 2021
Brickell (BBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brickell Biotech Doses First Patient in Second U.S. Pivotal Phase 3 Clinical Study
07:30am, Monday, 07'th Dec 2020
T opline results from the U.S. pivotal Phase 3 program anticipated in the fourth quarter of 2021 Sofpironium bromide gel, 5% (ECCLOCK ® ) recently launched in Japan by development partner, Kaken Phar
Brickell Biotech Announces Launch Date for Sofpironium Bromide Gel, 5% (ECCLOCK®) in Japan by its Development Partner, Kaken Pharmaceutical
07:00am, Wednesday, 18'th Nov 2020
Kaken plans to launch ECCLOCK ® for the treatment of primary axillary hyperhidrosis in Japan on November 26, 2020 - - - ECCLOCK ® placed on Japan's National Health Insurance (NHI) drug reimbursement
Brickell Biotech to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
08:00am, Monday, 16'th Nov 2020
BOULDER, Colo., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated pre
Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q3 2020 Results - Earnings Call Transcript
07:06pm, Thursday, 12'th Nov 2020
Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q3 2020 Results - Earnings Call Transcript
Brickell Biotech Reports Third Quarter 2020 Financial Results and Provides Corporate Update
04:01pm, Thursday, 12'th Nov 2020
Recently completed capital raise expected to fully fund U.S. pivotal Phase 3 program, with topline results anticipated in Q4 2021 - - - Initiated the Cardigan I study, the first of two U.S. pivotal Ph
